Login / Signup

Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan.

Marie Warrer MunchTine Sylvest MeyhoffMarie HellebergMaj-Brit Nørerregaard KjaerAnders GranholmCarl Johan Steensen HjortsøThomas Steen JensenMorten Hylander MöllerPeter Buhl HjortrupMik WetterslevGitte Kingo VesterlundLene RussellVibeke Lind JørgensenKlaus TjelleThomas BenfieldCharlotte Suppli UlrikAnne Sofie AndreasenThomas MohrMorten H BestleLone Musaeus PoulsenMette Friberg HitzThomas HildebrandtLene Surland KnudsenAnders MøllerChristoffer Grant SøllingAnne Craveiro BrøchnerBodil Steen RasmussenHenrik NielsenSteffen ChristensenThomas StrømMaria CronhjortRebecka Rubenson WahlinStephan JakobLuca CioccariBalasubramanian VenkateshNaomi HammondVivekanand JhaSheila Nainan MyatraChristian GluudTheis LangeAnders Perner
Published in: Acta anaesthesiologica Scandinavica (2020)
The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.
Keyphrases
  • coronavirus disease
  • sars cov
  • low dose
  • study protocol
  • clinical trial
  • phase iii
  • early onset
  • randomized controlled trial
  • phase ii
  • respiratory syndrome coronavirus
  • high dose